Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Temozolomide Plus Bevacizumab in Patients With Metastatic Melanoma Involving the Central Nervous System

NCT01048554 is registered in ClinicalTrials.gov with Mt. Sinai Medical Center, Miami as lead sponsor.

NCT NCT01048554
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01048554 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Temozolomide Plus Bevacizumab in Patients With Metastatic Melanoma Involving the Central Nervous System
Lead sponsor
Mt. Sinai Medical Center, Miami
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2009
Completion date
September 30, 2011
Enrollment
34 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma